Introduction and clinical adoption of new precision oncology treatments

It is through their research projects that healthcare professionals play an active role in the evolution of treatment plans. These optimized treatments will be made available to patients once they have been approved by Health Canada and adopted into healthcare processes. We'll be discussing inspiring examples in the field of precision oncology, from clinical research to the management of practice change in the healthcare network.

Facilitator

Réjean Lapointe, PhD
Theme leader Cancer, CRCHUM 
Full Professor, Department of Medicine, Université de Montréal

Speakers

Mark Basik, MD
Researcher, Institut Lady Davis
Assistant Professor, Surgery and oncology departments, Université McGill 

Rahima Jamal, MD, FRCPC. 
Hematologist and Medical Oncologist
Assistant Professor of Medicine, Université de Montréal
Medical Director, Therapeutic Innovations Unit, CRCHUM

Vanessa Samouelian,  MD, PhD
Assistant clinical professor, Department of Obstetrics-Gynecology, Faculty of Medicine, University of Montreal

Arnaud Blanchet Saint-Pierre, MD 
Hemato-oncologist, CISSS Bas-St-Laurent et Gaspésie